Variable | Overall survival | Recurrence-free survival | ||||
HR | 95% CI | P value | HR | 95% CI | P value | |
Age | 1.00 | 0.44 to 2.25 | 0.99 | 1.48 | 0.90 to 2.45 | 0.11 |
Surgical treatment | 1.00 | 0.52 to 1.89 | 0.99 | 1.74 | 0.86 to 3.49 | 0.11 |
FIGO stage | 1.47 | 0.92 to 2.34 | 0.10 | 1.67 | 1.22 to 2.30 | 0.001 |
Precursor lesions | 1.53 | 0.67 to 3.50 | 0.30 | 2.13 | 1.25 to 3.63 | 0.005 |
HPV status | 3.00 | 1.29 to 6.99 | 0.01 | 2.73 | 1.53 to 4.87 | 0.001 |
Silva pattern | 2.78 | 1.01 to 7.62 | 0.047 | 1.75 | 1.11 to 2.76 | 0.015 |
Histologic grade | 1.31 | 0.72 to 2.39 | 0.37 | 1.81 | 1.24 to 2.64 | 0.002 |
Lymphovascular invasion | 3.14 | 1.38 to 7.15 | 0.006 | 5.00 | 2.71 to 9.22 | 0.00001 |
Lymph node metastases | 3.93 | 1.66 to 9.29 | 0.002 | 5.44 | 3.12 to 9.48 | 0.00001 |
FIGO, International Federation of Gynecology and Obstetrics; HPV, human papillomavirus.